New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in…
Vaccine against Chikungunya in making
New Delhi: A new weapon against the debilitating infection of Chikungunya could soon be in the offing. A multi-country Phase II/III clinical trial of a…
First mRNA-based COVID 19 vaccine gets nod for phase II/III trial
New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India…
IIT-Madras Launches new programme to boost women leadership
New Delhi: Indian Institute of Technology-Madras has launched a new programme to boost its women leadership with an endowment fund raised from its alumni and…
Focus on management of adverse events in COVID-19 vaccination
New Delhi (India Science Wire): The operation guidelines prepared by the Central Government for the COVID-19 vaccination programme currently underway, provides a detailed roadmap to…
Elaborate mechanism to ensure Corona vaccine programme succeeds
New Delhi (India Science Wire): Considering that the highest level of political and administrative ownership, commitment, and support are needed to be sustained for the…